NE-3107 Alzheimer's, Parkinson's data boost Biovie

NE-3107 Alzheimer's, Parkinson's data boost Biovie

4.8
(179)
Write Review
More
$ 4.50
Add to Cart
In stock
Description

Researchers demonstrate e-stim reduces neural damage from strokes

Neurodegeneration

Alzheimer's disease

A wearable for deep tissue sensing, automated drug delivery

Novel insights into vulnerability and resilience in Parkinson's disease

Aging BioWorld

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

Saniona and Astronautx establish research collaboration in Alzheimer's disease

Grant supports Vesper Bio's development of sortilin inhibitors in Parkinson's disease

Alzheimer Disease Pipeline Update: Inside Look at Promising Agents

Blinded Data Presented at CTAD Suggest that NE3107 is Biologically Active and May Have Impact on Cognitive, Biomarker, and Imaging Endpoints Among Mild to Moderate Alzheimer's Disease Patients

Why Is BioVie Stock Trading Higher Today? - BioVie (NASDAQ:BIVI) - Benzinga

Perspectum raises $55M to expand US footprint

activity-dependent promoter

CZ-101 BioWorld